Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

Published:2000-03-06 Issue:4 Volume:45 Page:291-297
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Sch�ller Johannes,Cassidy Jim,Dumont Etienne,Roos Brigitte,Banken Ludger,Mori Kazushige,Reigner Bruno,Utoh Masahiro,Weidekamm Erhard,Durston Sarah

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800050043.pdf

Cited by 589 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges;Journal of Nanobiotechnology;2024-07-19

2. Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors;Frontiers in Oncology;2024-07-12

3. Prebiotic fibre mixtures counteract the manifestation of gut microbial dysbiosis induced by the chemotherapeutic 5-Fluorouracil (5-FU) in a validated in vitro model of the colon;BMC Microbiology;2024-06-26

4. 5-Fluorouracil for colorectal cancer: mechanism of action and metabolism;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2024-06

5. A pilot study investigating plasma pharmacokinetics and tolerance of oral capecitabine in carcinoma-bearing dogs;BMC Veterinary Research;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP